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Transfusion Therapy and 
Blood Banking 
in the Dog and Cat 
Randy L. Willer, DVM· 
Dean H. Riedesel, DVM, PhD·· 
INTRODUCTION 
The first successful transfusion of blood 
from one dog to another was first reported in 
1665 by Richard Lower. He anastomosed a 
carotid artery of a donor dog to the jugular 
vein of an acutely bled recipient. At this time 
in history, blo·od was regarded as the essence 
of life and useful only for its alleged psychic 
effects. It wasn't until 1818 that whole blood 
was used for its intrinisic value when a Lon-
don obstetrician initiated blood replacement 
therapy for postpartum hemorrhage. 1.2 •l 
As veterinary critical care becomes more 
and more sophisticated, the advantages of a 
basic knowledge of transfusion therapy and 
blood banking are increasingly apparent. 
The purpose of this article is to offer current 
knowledge on: 1) storing blood, 2) selection of 
donors, 3) blood grouping and crossmatching, 
4) blood collection, 5) indications for compo-
nent transfusions, 6) administration, and 7) 
complications. 
STORED BLOOD 
Erythrocyte viability is the major determi-
nant of storage time for erythrocytes in vari-
ous storage media. Some of the factors that 
affect the viability of stored blood include: 1) 
biochemical parameters, 2) storage media, 3) 
storage temperature, 4) storage container 
type, 5) frequency of gentle mixing during 
storage, and 6) collection technique. 
Biochemical Parameters 
There are several biochemical parameters 
that correlate with cellular viability during 
storage. These include intracellular ATP, 2-
°Dr. Willer is a 1985 graduate of the College ofVeteri-
nary Medicine at Iowa State University. 
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3-diphosphoglycerate (2-3-DPG), pH, and 
ammonia. 1 
In human erythrocytes, intracellular ATP 
decreases during storage. Erythrocytes with 
decreased ATP levels have rigid cell mem-
branes, resulting in rapid removal from the 
circulation by the reticuloendothelial system.1 
In addition, ATP, being a phosphoric com-
pound, affects the oxygen dissociation 
curve. 6 •7 The ATP content may not be as im-
portant in cellular viability in dogs as it is in 
humans. 
Another biochemical change that occurs in 
stored blood is the decrease in 2-3-diphos-
phoglycerate (2-3-DPG) levels. 2-3-DPG is 
an organic phosphate substance found in 
RBC's that facilitates a shift of the oxygen dis-
sociation curve to the right. 7 As storage time 
increases, the concentration of 2-3.-DPG de-
creases and the curve shifts to the left (Fig. 1). 
As a result, hemoglobin releases less oxygen 
to the tissues for a given partial pressure. 1.l.S 
Because of tremendous restoration capabili-
ties, the recipient is able to restore normal 2-
3-DPG levels in the transfused cells within 24 
hours. RBC's totally depleted of 2-3-DPG 
can regain 50% of the normal level within 24 
hours.1.l 
Blood depleted of 2-3-DPG or blood stored 
greater than 2 weeks should not be used in a 
patient requiring large amounts of transfused 
blood in a short time or a patient particularly 
sensitive to tissue hypoxia because the animal 
may deteriorate before 2-3-DPG levels are 
restored. 1.7 
Since the normal metabolism of the cells 
during storage does not cease, they utilize glu-
cose and produce lactic acid resulting in a de-
crease in pH. The acidity will cause a right 
shift of the oxygen dissociation curve, increas-
ing the oxygen-unloading ability at the tissue 
level. Citrate in the various storage media is 
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metabolized to an alkaline byproduct within 
minutes lifter transfusion and this tends to ne-
gate untoward effects of the acid pH of stored 
blood. Even so, when using blood stored for 
prolonged periods it may be advisable to in-
clude some sodium bicarbonate in the process 
of transfusion to aid maintenance of homeos-
tasis in the patient. 1.6 
Another biochemical parameter of stored 
blood is the increase of ammonia content. No 
clinically significant side effects of increased 
ammonia content of stored blood have been 
seen, although ammonia toxicity may be a 
problem in patients with reduced hepatic 
function in which the toxicity is potentiated 
by hypoxia. 
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Figure 1. Oxygen Dissociation Curve. The 
curve shifts to the left during 1,2,3,4,5 weeks of 
storage." 
Storage Media 
Various storage media are available to pre-
serve the viability of the erythrocytes and the 
oxygen-carrying capacity of collected blood. 
Currently recommended anticoagulants in-
clude citrate phosphate dextrose (CPD), ci-
trate phosphate dextrose adenine (CPDA-l), 
acid citrate dextrose (ACD), storage media 
for blood (8MB), and heparin. I 
The quantity of citrate in the media is suffi-
cient to bind the ionized calcium present in 
whole blood, and thus inhibits several steps in 
the coagulation cascade. The presence of dex-
trose in the media allows generation of ATP 
through glycolytic activity. Maintenance of 
ATP levels correlates with red cell viability. 
The addition of adenine to the preservative 
CPDA-l promotes red cell ATP production 
and lengthens the shelf-life. Finally, the addi-
tion of the phosphoric compounds to blood 
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helps maintain a normal oxygen dissociation 
curve. 6 •7 
The storage times of the various media are 
summarized in Figure 2. Note that heparin 
has no preservative capabilities. I •lo Feline 
erythrocytes stored in ACD are viable for at 
least 30 days and retain high erythrocyte 
viability.l.g 
Storage media for blood is similar to ACD 
but has additional components that keep ery-
throcytic viability above 70% for 6 weeks. At 
6 weeks the oxygen carrying capacity of blood 
stored in 5MB equals that of 2-week-old ACD 
blood. The 5MB is not commercially avail-
able. Formulations for 5MB and ACD are 
listed in Table 1.18 
TABLE 1 Formulations for Storage Medium 
for Blood (SMB) and Acid-Citrate-Dextrose 
(ACD) Solution. 18 
Factor 
Dextrose (g) 
Sodium citrate (g) 
Citric acid (g) 
Sodium dibasic phosphate (g) 
Trisodium ascorbate-2-
phosphate (g) 
Water qs (m) 
pH 
Milliliters of solution to 
preserve 1 00 ml of blood 
5MB 
2.55 
2.63 
0.325 
0.222 
0.406 
100 
7.0· 
17.5 
• Adjusted with sodium hydroxide. 
Storage Temperatures 
ACD 
1.47 
1.32 
0.48 
100 
5.0 
25 
Whole blood and packed red cells are stored 
at I-6°C to slow glycolytic activity, to avoid 
rapid depletion of glucose and adenine, and to 
decrease proliferation of bacteria. 7 Blood 
should be thawed slowly at room tempera-
ture. 
Storage Containers 
Three types of containers are used to store 
blood: glass vacuum bottles, plastic bags, and 
plastic syringes. I Plastic collection bags are 
preferable to vacuum bottles for four reasons: 
1) bags are non-breakable, 2) bags require 
less storage space before and after collection, 
3) gravity-filled bags decrease mechanical 
trauma to red cells and increase red cell 
viability, and 4) platelets do not adhere to the 
walls of plastic bags.1olo A possible disadvan-
tage is the presence of the phthalate ester plas-
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ticizer that has been identified in human tis-
sues following transfusion. The significance of 
this is unknown. 7 Plastic syringes are used for 
collection of feline blood. 
While blood is being stored, frequent 
(daily) gentle mixing helps maintain ATP, 
glucose, and 2-3-DPG levels. 1•3 
canis, Hemobartonella canis, and Trypanosoma 
cruzi should be obtained, depending on the 
geographical location of the practice. In addi-
tion, donors should be free of fleas, ticks, and 
intestinal parasites (especially hook-
worms). 1.2.11 
The requirements for selection of the donor 
FIGURE 2 Common Anticoagulants - Preservatives.' 
Agent 
Heparin 
Acid Citrate 
Dextrose (ACD) 
Citrate Phosphate 
Dextrose (CPD) 
Citrate Phosphate 
Dextrose with 
Adenine (CPDA-1) 
FDA * Shelf-life 
of collected 
blood stored 
at 1-6°C 
24 hours 
21 days 
21 days 
35 days 
Dosage 
250 u heparin/ 
50 ml whole 
blood 
10 ml ACDI 
60 ml whole 
blood 
Premeasured 
in commercial 
administration 
bags or 
vacuum bottles 
same as ACD 
same as ACD 
Comments 
No preservative 
capabilities 
1. Acidic Solution 
2. Hypotonic to RBC's 
so may be removed 
from circulation 
earlier. 
3. Maintains lower 2-3-
DPG levels than 
other commercially 
available blood 
preservatives 
1. Increased % viable 
cells at 21 days 
over ACD. 
1. Adenine provides 
substrate for RBC's 
to synthesize ATP 
during storage. 
Results in improved 
viability. 
* As licensed by FDA. The shelf-life, or maximum allowed storage time, is defined as the expectation that 
at least 70% of the transfused cells remain in the recipient's circulation 24 hours after transfusion. 
SELECTION OF DONORS 
The canine donor should be lean, 2-5 
years of age, weigh at least 25 kg, be in good 
physical condition, have a packed cell volume 
(PCV) of at least 40 %, and be adequately im-
munized. It should not have received prior 
blood transfusions or had a prior pregnancy. 
Females should be spayed because of estrogen 
influences on platelet number and func-
tion. 1 •2 •11 
Potential donors should be blood typed and 
vaccinated for distemper, hepatitis, leptos-
pirosis, parainfluenza, and parvovirus. A 
complete blood count, serum chemistry pro-
file, urinalysis, fecal examination, and a 
Knotts test should be performed. Serological 
tests for Brucella canis and serum titers for in-
fectious agents such as Ehrlichia canis, Babesia 
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cat are similar to those of donor dogs except 
the donor shoud be a lean mature 5 kg animal 
with a PCV greater than 35 %. Donor cats 
should be serologically negative for Toxoplasma 
gondii, Hemobartonella felis, feline infectious 
peritonitis, and feline leukemia. 1 
If donors are used repeatedly they need ad-
ditional dietary supplementation of iron, pro-
tein, Vitam-in Bll , folic acid, and pyridoxine. 
Meat protein-derived diets ensure an ade-
quate amount of hemoglobin precursors. 2 
BLOOD GROUPING 
Eight specific antigens have been identified 
on the surface of canine erythrocytes (Table 
2). These antigens determine the various 
blood groups. 
The currently accepted acronym for the 
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canine blood group is DEA (dog erythrocyte 
antigen). I The blood group antigens DEA 1.1 
and DEA 1.2 are allelic and never occur on 
TABLE 3 Canine Blood Groupsl9 
Nomenclature Common Name Incidence· 
DEA-l.l 
DEA-1.2 
DEA-3 
DEA-4 
DEA-5 
DEA-6 
DEA-7 
DEA-8 
Al 
Al 
B 
C 
D 
F 
Tr 
He 
"In random dog population. 
40 
20 
5 
98 
25 
98 
45 
40 
the same red blood cell, but may occur with 
other canine erythrocyte antigens. All of the 
blood group antigens are capable of stimulat-
ing the formation of specific antibodies (isoan-
tibodies). The group with the greatest poten-
tial for antigenic stimulation is DEA 1.1. 
Reactions to DEA 1.2 are less severe but can 
be clinically significant. Naturally occurring 
isoantibodies do not occur against DEA 1.1 or 
DEA 1.2. However, approximately 15% of 
the dog population has natural isoantibodies 
against DEA 3, 4, 5, and 7 with anti-DEA 7 
reactions occurring most frequently. As a re-
sult, adverse reactions are possible on initial 
transfusions but rarely occur. I •3 
The canine blood donor for a practice 
should be negative for DEA 1.1 and 1.2. 
There are several reasons to avoid possible 
transfusions of DEA 1.1 or DEA 1.2 positive 
blood into a recipient negative for these anti-
gens: 1) the recipient may produce antibodies 
and cause delayed hemolysis 7 -10 days later; 
2) sensitization of the recipient will occur to 
subsequent transfusion of blood containing 
DEA 1.1 or DEA 1.2; 3) immediate transfu-
sion reactions in an already sensitized recipi-
ent; and 4) the possibility of hemolytic disease 
of newborn pups that have received isoantibo-
dies from a sensitized dam. For these reasons, 
it is recommended that canine blood donors 
be typed negative for DEA 1.1 and DEA 1.2.3 
In the feline, there are three specific blood 
group antigens associated with the erythrocyte 
membranes. The most common blood group 
reported was Type A with a 73 % occurrence. 
Type B was found in 26 % and Type AB in 
less than 1 % of the cat population.1.12 The 
value of blood typing a feline donor is un-
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known at this time. But, since naturally oc-
curring antibodies against other blood types 
may exist in the cat and antibody production 
occurs after exposure to a different blood type, 
crossmatching before all transfusions in the 
cat· is advisable. Blood typing is available 
through Stormont Laboratories, 1237 E. 
Beamer St., Woodland, CA 95695. 
CROSSMATCHING 
The best alternative to blood typing is 
crossmatching the donor and recipient blood. 
The use of crossmatched blood does not pre-
vent sensitization of the recipient for future 
transfusions if the donor cells contained non-
identical alloantigens. 15 
Two types of crossmatching are performed, 
major and minor. The major crossmatch uses 
donor cells and recipient serum and deter-
mines whether the recipient has antibodies 
against the donor cells. The minor crossmatch 
uses recipient cells and donor serum which 
detect whether there are antibodies in the 
donor serum against the recipient cells. Both 
tests should be performed on fresh blood. 15 
Donor and recipient controls are set up along 
with the major and minor crossmatch. 
COLLECTION 
Various sites of collection in the dog and cat 
include: 1) cephalic veins, 2) jugular veins, 3) 
cardiac ventricles, 4) femoral arteries, and 5) 
carotid arteries. 1.10 
Of the various collection sites for the dog, 
the femoral artery is least traumatic to red 
blood cells and platelets. 3 
If syringes are being used or mechanical 
vacuum equipment is available for plastic bag 
collection, the jugular vein is preferred be-
cause of its size and access. I •S 
The animal should be anesthetized and the 
collection site should be surgically prepared so 
that strict aseptic technique may be fol-
lowed. t •7 Blood collection should be rapid, un-
interrupted and performed through a single 
puncture site to prevent blood cell damage 
and the activation of coagulation factors. 3 
When using the femoral artery, pressure 
should be applied over the vessel for 5 -1 0 
minutes to control hemorrhage. I Blood and 
anticoagulant should be gently mixed during 
the collection process to prevent clots from 
forming. The amount of blood that can be 
withdrawn safely from a dog is about 22ml/kg 
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(10 mIllb) of body weight every 7 -10 days. A 
cat can donate this amount safely every 10 
days. On an emergency basis, additional 
blood can be taken after a 5 day recovery 
period. If the erythrocytes are infused back 
into the donor following the harvesting of 
plasma, blood can be collected every two 
days. I 
By withdrawing 22 mIlkg, a 20 kg dog can 
yield one unit of whole blood per collection. A 
unit consists of 450 ml of blood collected into 
a plastic bag containing 63 ml of the anti-
coagulant and preservative. 16 Where large 
volumes are required, it has been suggested to 
collect from normal patients being eu-
thanized. Permission should be obtained from 
the owners.IO Complete exsanguination of a 
25 kg dog yields an average of 1000 ml of 
blood and a 5 kg cat yields an average of 150 
ml of blood. I The quantity of blood needed 
for transfusion can be calculated from the 
equation in Figure 3. The recipient's clinical 
signs and physiologic status must also be con-
sidered. 
volume expansion. If coagulation factors and 
platelets are needed, blood should be used 
within 8 -12 hours after collection because the 
viability of these components is rapidly lost. 15 
Surgical Patient 
It is recommended that surgical candidates 
have a minimum PCV of 27-30%. During 
surgery the PCV should be maintained above 
20%. When possible, transfusions should be 
given at least 48 hours prior to surgery. 
Packed red cells are the treatment of choice if 
serum protein values are normal. During sur-
gery, if blood loss is great, whole blood trans-
fusion or autotransfusion may be indi-
cated. 3 •15 
Anemia 
In anemia of hemorrhage or hemorrhagic 
shock, replacement of blood volume is of pri-
mary importance. PCV in the first 8-12 
hours posthemorrhage is not an accurate indi-
cator of the extent of hemorrhage. The PCV 
will not reflect the loss of blood until fluids are 
FIGURE .1 Calculation of donor blood volume required. '9 
Volu~e of ;;:;: wt. X 70 (mllkg) [ recipient ] 
blood reqUIred (ml) (kg) 
X Hb rise wanted (gm/dl) 
donor's Hb (gm/dl) 
INDICATIONS FOR WHOLE BLOOD 
AND BLOOD COMPONENT 
TRANSFUSION THERAPY 
Separating whole blood into its various 
components is the most efficient way to use 
blood or blood products. 15 The varous compo-
nents used include: 1) packed red blood cells, 
2) plasma, 3) fresh frozen plasma, 4) cryopre-
cipitate plasma, 5) platelet-rich plasma, 6) 
plasma derivatives, and 7) leukocytes. 7.15 
Indications for whole blood transfusions 
are: hemorrhage (including bleeding disor-
ders), hemorrhagic shock, nonregenerative 
anemia, and hemolytic anemias. In anemic 
conditions that can be treated with packed red 
cells or iron, whole blood is not necessary un-
less the anemia is severe enough to be life 
threatening. 15 
Whole blood provides a source of erythro-
cytes for carrying oxygen to the tissues and it 
supplies plasma proteins necessary for oncotic 
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pulled into the vascular space diluting the 
erythrocytes. Therefore, crystalloid solutions 
such as Lactated Ringers Solution are sug-
gested for the initial replacement of blood vol-
ume. 1 
If 'the PCV falls acutely to 20-25% and 
adequate hydration has been accomplished, 
whole blood should be given at a rate of 13-
22 ml/kg of body weight. This can be re-
peated once or twice during the first 24 hours 
until stabilization of the pev above 20 % . I 
A more specific guideline for the quantity 
of blood necessary to elevate the packed cell 
volume to a desired level is shown in Figure 5. 
Transfusions are rarely indicated for re-
generative anemias but may be indicated for 
chronic nonregenerative nonhemolytic ane-
mias. Many animals with a chronic anemia 
have 2-3-DPG levels two to three times nor-
mal and their oxygen transport and delivery is 
adequate. The patient should have clinical 
signs of anemic anoxia such as anorexia, ex-
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cessive weakness, orthopnea, or· edema before 
therapy is initiated. 3 The PCV necessitating 
the administration of transfusion therapy is 
variable for chronic nonregenerative ane-
mia. 1.3 When the PCV is less than 10 % in 
chronic anemia, transfusion may be indi-
cated. J Another source establishes the PCV at 
15 % for the dog and 12 % for the cat. 1 
In autoimmune hemolytic anemia, transfu-
sions should be used only as a life saving 
measure because they can accelerate hemoly-
sis. t.J 
Transfusions may be indicated in non-
autoimmune hemolytic anemias associated 
with diseases such as Heinz-body anemias in 
cats and onion poisoning in dogs if the PCV 
falls to a life-threatening level. 1 
Packed red cells are specifically indicated in 
patients that require improved oxygen carry-
ing capacity but do not require volume re-
placements. t6 
Hypoproteinemia 
Hypoproteinemia exists when there is a 
normal hematocrit and the total plasma pro-
tein is less than 5g/dl. 1.2 Protein replacement 
therapy may be indicated if the albumin levels 
are less than 1.5 g/dl. 1.2 Fresh or frozen 
plasma should be transfused at a rate of 6-12 
ml/kg body weight. The frequency of plasma 
administration depends on the protein deficit 
and ongoing 10ss.1 There is a danger of vol-
ume overload with the use of whole-blood 
transfusion for the treatment of hypoproteine-
mia. 1 Harvested plasma can be stored at 
- 40° to -70°C for up to one year or in a 
household freezer for 3 months. t5 
COAGULOPATHIES 
Disseminated Intravascular Coagulation 
There is considerable controversy over the 
treatment of this condition. Currenly mild 
DIC is treated with heparin or aspirin. Severe 
DIC is treated with heparin and replacement 
of clotting factors with fresh whole blood or 
fresh plasma. 1 Other sources say fresh whole 
blood is the treatment of choice in the actively 
bleeding DIC patient. J 
Thrombocytopenia 
The underlying cause of thrombocytopenia 
should be identified and treated if possible. 
Fresh whole blood may be administered but it 
should be noted that large volumes of blood 
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are necessary to significantly elevate the recip-
ient's thrombocyte count. Platelet-rich plasma 
is superior to whole blood in treating throm-
bocyte disorders. Harvesting platelet-rich 
plasma has been described. IS 
Congenital or Acquired Factor and 
Vitamin K Deficiencies 
For both hereditary and acquired causes of 
bleeding disorders, whole blood, plasma, or 
plasma components can be administered. 
Cryoprecipitates are used to treat inherited 
bleeding disorders and are rich in the antihe-
mophilic factor, Von Willebrand's factor, and 
fibrinogen. Actions of factors IX, XI, and 
XIII are also exhibited. 15 
.Vitamin K therapy may be all that is 
needed if Vitamin K deficiency is suspected 
such as in warfarin-related poisonings. 1 
Liver Disease 
The liver is the primary site of production 
of plasma procoagulants and numerous he-
mostatic defects may be present in liver dis-
ease. Whole blood or, preferably, fresh plasma 
can be given to patients with severe liver dis-
ease. 1 
BLOOD ADMINISTRATION 
Blood should be administered through a fil-
ter system to minimize transfusion of mi-
croaggregates of platelets, white blood cells, 
fat, and emboli that may occur due to poor 
collection techniques. 7.3 
Blood should be warmed to 37°C to avoid 
hypothermia. Excessive heat should not be 
used to accelerate blood warming because fi-
brinogen precipitates and red blood cells he-
molyze if warmed to 50° C. Autoagglutina-
tion occurs when temperatures exceed 45° 
C. 1S •3 
Blood is most commonly administered via 
the cephalic or jugular veins. Neonatal canine 
and feline patients can be infused into the me-
dullary cavity of the femur or humerus. Sys-
temic absorption of blood infused into the me-
dullary cavity is rapid, 95.3 % within five 
minutes. Blood can also be infused into the 
patients peritoneal cavity.15.16 The disadvan-
tages of the latter two techniques include: 1) 
decreased numbers of viable red cells that en-
ter the recipients circulatory system, 2) de-
creased life span of the transfused erythro-
cytes, 3) pain, and 4) possibility of 
introducing peritonitis or osteomyelitis. 15.16 
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An initial intravenous transfusion rate of 
0.25 ml/kg over a 30-minute period is sug-
gested during which the patient should be 
watched carefully for transfusion reactions. IS 
The recommended transfusion rate of 
whole blood in dogs is less than 22 ml/kg/day. 
A hypovolemic patient may receive up to 22 
ml/kg/hour. Dogs in cardiac failure cannot 
tolerate rates exceeding 4 mllkg/hour. IS 
In an adult cat weighing 2-3 kg, up to 40 
ml of whole blood can be given intravenously 
over a 30-minute period. The safest technique 
is frequent infusion of small amounts of 
blood. U 
Crystalloid solutions may be administered 
simultaneously with whole blood, packed red 
cells, or plasma to aid in correction of hypov-
olemia and restoration of cardiac output. 
However, only normal saline or balanced elec-
trolyte solutions without calcium should be 
administered through the same catheter. Solu-
tions containing calcium, such as Lactated 
Ringers, should be administered using sepa-
rate tubes because of the possibility of clotting 
within a common tube. Dextrose solution 
may cause autoagglutination, hemolysis or 
both. I •3 •16 
COMPLICATIONS 
Blood transfusions can produce various ad-
verse reactions. The most effective means of 
decreasing the incidence of transfusion reac-
tions is to avoid transfusion therapy unless it 
is absolutely indicated. ls.16 
Transfusion reactions can be divided into 
immunologically and nonimmunologically 
mediated reactions. These are summarized in 
Figure 4. 
Nonimmunologically mediated transfusion 
reactions include vascular overload and fever. 
Vascular overload may result in clinical signs 
of dyspnea, cough, and vomiting. Nonim-
munologic fever results from break in aseptic 
technique during collection, administration, 
or storage of blood. ls .. 16 
The most severe transfusion reactions are 
immunologically mediated hemolytic reac-
tions. Severe transfusion reactions in both the 
dog and cat may begin within seconds to min-
utes. Il •17 
In immediate onset hemolysis, the transfu-
sion should be stopped immediately and sa-
line given intravenously. Shock treatment 
may be necessary. Despite the apparent sever-
ity of acute hemolytic reactions, they are usu-
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ally not fatal. The patient typically is fully re-
covered in 12 to 24 hours. IS 
It is important to carefully monitor the pa-
tient during transfusion therapy and follow 
the guidelines for proper administration of 
blood components. 
FIGURE 4 Summary of Transfusion Com-
plications. 
Summary of Nonimmunologic Reactions to 
Transfusion. 
A. Vascular Overload 
1. Cough 
2. Dyspnea 
3. Vomiting 
B. Fever 
C. Aysmptomatic Hemolysis 
1. Physical trauma to red blood cells 
a. Freezing 
b. Overheating 
c. Mixing red cells with nonisotonic 
solutions 
Summary of Immediate Immunologic Reactions 
A. Hemolysis Due to Red Cell Incompatibility 
1. Restlessness and anxiety 
2. Urticaria/pruritus 
3. Muscle tremors 
4. Nausea/salivation/vomiting 
5. Fever 
6. Apnea and/or tachypnea 
7. Tachycardia 
8. Fecal and/or urinary incontinence 
9. Anuria/renal failure 
10. Convulsions 
B. N onhemolytic Reactions 
'1. Urticaria/pruritus usually due to antibody 
to plasma protein 
2. Anaphylaxis due to antibody to IgA 
3. Fever due to antibody to leukocytes 
Summary of Delayed Immunologic Reactions 
A. Hemolysis due to anamnestic antibody to cell 
antigen 
1. Clinical signs similar to immediate 
immunologic reactions but usually not as 
profound 
2. Drop in PCV 2-21 days post-transfusion 
B. Delayed phagocytosis approximately 7-10 
days post-incompatible transfusion due to 
antibody formation 
C. Post-transfusion purpura due to antiplatelet 
antibodies 
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Front Exit Chute Gate 
* Manual and Automatic 
* Easy entry and walk-
through exit * Fast release 
* Manual-fast acting for herd 
work * Automatic - one man 
control of gate and COWS ... 
no pre-adjusting of gate 
PRIEFERT Squeeze Chutes 
NOW WITH CONTOURED, 
BODY-SHAPED SIDES, FOR MAXIMUM 
ANIMAL RESTRAINT AND STABILITY 
One position, one man operation makes 
fast work of one or two animals or a whole 
herd. Six easy-open top gates and two 
lower panels permit quick treatment of ani-
mal in any area. Powerful side squeeze. 
Head chains for quick, safe, sure head re-
straint. Manual or automatic headgate. Fast 
exit through head gate or complete side 
opening. 
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